IlluminOss Medical Appoints Clive Ridgwell as Vice President of Sales

New Hire Will Advance the Commercialization Strategy for IlluminOss' Fracture Repair System Internationally

EAST PROVIDENCE, RI--(Marketwired - Jul 21, 2015) -  IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced the appointment of Clive V. Ridgwell as vice president of sales. Ridgwell brings more than 30 years of commercial experience in medical device fields which he will apply to the further development of IlluminOss' product strategy in global markets. 

Ridgwell joins IlluminOss from Zimmer Inc., where he spent the last 21 years working in a number of senior executive roles within its European, Middle Eastern and African operations. Most recently, he served as vice president of the Trauma Division. Prior to that, he held the positions of vice president for the Spine Division and managing director and general manager of Zimmer UK, Nordic, Scandinavia and Southern Africa.

"Clive Ridgwell's extensive operational expertise has proven fundamental to the development of medical device companies both at a geographical and product-specific level and we are pleased to welcome him to the IlluminOss team," said Robert Rabiner, president and CEO of IlluminOss Medical. "He will be integral to the advancement of our commercialization strategy in Europe."

The IlluminOss System has proven to be extremely successful in the minimally invasive treatment of complex fractures in over a thousand patients in Europe, where it is commercially available and has been in clinical use since 2010. Using a light-curable polymer, contained within an expandable balloon catheter, IlluminOss' intramedullary patient-conforming implant achieves the repair and stabilization of fractures, allowing patients to resume their daily living activities in a fast, minimally invasive fashion.

"I am excited to be part of a company with a groundbreaking technology that is well positioned to truly change the way fracture repair can be approached," said Ridgwell. "I look forward to applying my cumulative career experience to advancing the successful adoption of the IlluminOss Systems in many international markets so patients and surgeons alike can reap the benefits of this new method."

About IlluminOss

IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, the IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The system utilizes a light-curable polymer, contained within an expandable balloon catheter, to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in international countries under a CE Mark for approved clinical applications through both a direct sales force and distribution networks.

The IlluminOss products are Investigational Devices; limited by Federal law to Investigational Use and are not approved for sale in the USA.

Contact Information:

Media Contact:
Jordan Bouclin
SVM Public Relations

(401) 490-9700